Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
PaperCitations, authors & open-access status
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 564 citations, 2021 year and closed oa status.
564
Citations
2021
Year
closed
OA Status